Variant report
Variant | nsv981859 |
---|---|
Chromosome Location | chr8:5811960-5819941 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375931208 | chr8:5815207-5815208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569951750 | chr8:5815227-5815228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574323379 | chr8:5815242-5815243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2816400 | chr8:5815335-5815336 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs573721904 | chr8:5815355-5815356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534718355 | chr8:5815357-5815358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552788454 | chr8:5815397-5815398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556431149 | chr8:5815409-5815410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544588090 | chr8:5815441-5815442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184045385 | chr8:5815443-5815444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2816401 | chr8:5815474-5815475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs187973107 | chr8:5815475-5815476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370059358 | chr8:5815477-5815478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2816402 | chr8:5815485-5815486 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs191232052 | chr8:5815486-5815487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529421693 | chr8:5815487-5815488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547919135 | chr8:5815494-5815495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565317632 | chr8:5815503-5815504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183820944 | chr8:5815504-5815505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187116933 | chr8:5815505-5815506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533403135 | chr8:5815521-5815522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551779559 | chr8:5815528-5815529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570038404 | chr8:5815542-5815543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79606060 | chr8:5815550-5815551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548967605 | chr8:5815552-5815553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111510260 | chr8:5815604-5815605 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7830786 | chr8:5815622-5815623 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534507988 | chr8:5815624-5815625 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs4875658 | chr8:5815649-5815650 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs577295786 | chr8:5815673-5815674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185194296 | chr8:5815688-5815689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4875659 | chr8:5815704-5815705 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs2816403 | chr8:5815774-5815775 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs544096528 | chr8:5815776-5815777 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190120759 | chr8:5815794-5815795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs193168970 | chr8:5815805-5815806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574217463 | chr8:5815822-5815823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372717192 | chr8:5815824-5815825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536440359 | chr8:5815883-5815884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs550400385 | chr8:5815884-5815885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541252262 | chr8:5815891-5815892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559915692 | chr8:5815904-5815905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567025552 | chr8:5815919-5815920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148185171 | chr8:5815928-5815929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563682607 | chr8:5815948-5815949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533675831 | chr8:5815965-5815966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530806521 | chr8:5815968-5815969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549298730 | chr8:5815969-5815970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141217022 | chr8:5816029-5816030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548770357 | chr8:5816033-5816034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:5815200-5816000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr8:5815400-5816000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr8:5815600-5815800 | Weak transcription | Fetal Heart | heart |
4 | chr8:5815800-5816000 | Enhancers | Fetal Heart | heart |
5 | chr8:5816000-5818600 | Weak transcription | Fetal Heart | heart |
6 | chr8:5816000-5819200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr8:5816000-5819400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr8:5818600-5820600 | Enhancers | Fetal Heart | heart |
9 | chr8:5819200-5820600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
10 | chr8:5819400-5820600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr8:5819600-5820800 | Enhancers | Fetal Brain Male | brain |
12 | chr8:5819800-5820200 | Enhancers | Fetal Lung | lung |
13 | chr8:5819800-5820800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |